KRAS mutations are genetic alterations in the KRAS gene, frequently involved in the development of various cancers, including lung, colorectal, and pancreatic cancers. These mutations lead to continuous activation of KRAS protein, promoting uncontrolled cell division and tumor growth, making them critical targets for cancer therapy.